457 related articles for article (PubMed ID: 10711638)
1. Cutaneous dysplastic naevi in uveal melanoma patients: markers for prognosis?
Tóth-Molnár E; Hammer H; Oláh J
Melanoma Res; 2000 Feb; 10(1):36-9. PubMed ID: 10711638
[TBL] [Abstract][Full Text] [Related]
2. [Connection between uveal melanoma and dysplastic naevus syndrome].
Hammer H; Tóth-Molnár E; Oláh J; Dobozy A
Magy Onkol; 2005; 49(1):15-8. PubMed ID: 15902328
[TBL] [Abstract][Full Text] [Related]
3. Dysplastic naevi with moderate to severe histological dysplasia: a risk factor for melanoma.
Shors AR; Kim S; White E; Argenyi Z; Barnhill RL; Duray P; Erickson L; Guitart J; Horenstein MG; Lowe L; Messina J; Rabkin MS; Schmidt B; Shea CR; Trotter MJ; Piepkorn MW
Br J Dermatol; 2006 Nov; 155(5):988-93. PubMed ID: 17034530
[TBL] [Abstract][Full Text] [Related]
4. The association of cutaneous and iris nevi with uveal melanoma: a meta-analysis.
Weis E; Shah CP; Lajous M; Shields JA; Shields CL
Ophthalmology; 2009 Mar; 116(3):536-543.e2. PubMed ID: 19167086
[TBL] [Abstract][Full Text] [Related]
5. Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi.
Richtig E; Langmann G; Müllner K; Smolle J
Ophthalmologica; 2004; 218(2):111-4. PubMed ID: 15004500
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi.
Gandini S; Sera F; Cattaruzza MS; Pasquini P; Abeni D; Boyle P; Melchi CF
Eur J Cancer; 2005 Jan; 41(1):28-44. PubMed ID: 15617989
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous dysplastic naevi: risk factor for uveal melanoma.
Hammer H; Tóth-Molńar E; Oláh J; Dobozy A
Lancet; 1995 Jul; 346(8969):255-6. PubMed ID: 7616832
[No Abstract] [Full Text] [Related]
8. Melanoma versus dysplastic naevi: microtopographic skin study with noninvasive method.
Mazzarello V; Soggiu D; Masia DR; Ena P; Rubino C
J Plast Reconstr Aesthet Surg; 2006; 59(7):700-5. PubMed ID: 16782565
[TBL] [Abstract][Full Text] [Related]
9. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma.
Banky JP; Kelly JW; English DR; Yeatman JM; Dowling JP
Arch Dermatol; 2005 Aug; 141(8):998-1006. PubMed ID: 16103329
[TBL] [Abstract][Full Text] [Related]
10. [From dysplastic nevus to malignant melanoma--a study of 4 anatomoclinical cases of dysplastic nevus syndrome].
Huynh Do P; Joris F
Praxis (Bern 1994); 1997 Nov; 86(47):1854-9. PubMed ID: 9480503
[TBL] [Abstract][Full Text] [Related]
11. Minichromosome maintenance protein expression in benign nevi, dysplastic nevi, melanoma, and cutaneous melanoma metastases.
Boyd AS; Shakhtour B; Shyr Y
J Am Acad Dermatol; 2008 May; 58(5):750-4. PubMed ID: 18249467
[TBL] [Abstract][Full Text] [Related]
12. [Dysplastic nevi and the risk of melanoma: a guideline for patient care. Nederlandse Melanoom Werkgroep van de Vereniging voor Integrale Kankercentra].
Bergman W; van Voorst Vader PC; Ruiter DJ
Ned Tijdschr Geneeskd; 1997 Oct; 141(42):2010-4. PubMed ID: 9550752
[TBL] [Abstract][Full Text] [Related]
13. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population.
Augustsson A; Stierner U; Rosdahl I; Suurküla M
Acta Derm Venereol; 1991; 71(6):518-24. PubMed ID: 1685835
[TBL] [Abstract][Full Text] [Related]
14. Dysplastic naevus vs. in situ melanoma: digital dermoscopy analysis.
Burroni M; Sbano P; Cevenini G; Risulo M; Dell'eva G; Barbini P; Miracco C; Fimiani M; Andreassi L; Rubegni P
Br J Dermatol; 2005 Apr; 152(4):679-84. PubMed ID: 15840098
[TBL] [Abstract][Full Text] [Related]
15. Conjunctival and uveal melanoma in the dysplastic nevus syndrome.
McCarthy JM; Rootman J; Horsman D; White VA
Surv Ophthalmol; 1993; 37(5):377-86. PubMed ID: 8484171
[TBL] [Abstract][Full Text] [Related]
16. Genetic study of familial uveal melanoma: association of uveal and cutaneous melanoma with cutaneous and ocular nevi.
Smith JH; Padnick-Silver L; Newlin A; Rhodes K; Rubinstein WS
Ophthalmology; 2007 Apr; 114(4):774-9. PubMed ID: 17207529
[TBL] [Abstract][Full Text] [Related]
17. Spitz naevi may express components of the plasminogen activation system.
Ferrier CM; Van Geloof WL; Straatman H; Van De Molengraft FJ; Van Muijen GN; Ruiter DJ
J Pathol; 2002 Sep; 198(1):92-9. PubMed ID: 12210068
[TBL] [Abstract][Full Text] [Related]
18. Epiluminescence microscopy features of cutaneous malignant melanoma metastases.
Schulz H
Melanoma Res; 2000 Jun; 10(3):273-80. PubMed ID: 10890382
[TBL] [Abstract][Full Text] [Related]
19. CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type.
Scala S; Ieranò C; Ottaiano A; Franco R; La Mura A; Liguori G; Mascolo M; Staibano S; Ascierto PA; Botti G; De Rosa G; Castello G
Cancer Immunol Immunother; 2007 Oct; 56(10):1589-95. PubMed ID: 17410362
[TBL] [Abstract][Full Text] [Related]
20. [Nevus and malignant cutaneous melanoma].
Morales Suárez-Varela MM; Llopis González A; Lacasaña Navarro M; Ferrándiz Ferragud J
Rev Sanid Hig Publica (Madr); 1991; 65(3):233-8. PubMed ID: 1801183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
